Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1210Source: DataRank Database

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.02)OA: hybridTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Monica M. Farley,Raymond F. Schinazi ORCID,Vincent C. Marconi ORCID,Boghuma K Titanji ORCID

Live enrichment

PubMed:32797226 PMC:PMC7454400 OpenAlex:https://openalex.org/W3048887052

Emory University Center

Grant: AI050409

National Institutes of Health

Grant: 5-R01-MH116695

NIMH NIH HHS

Grant: R01 MH116695

NIAID NIH HHS

Grant: P30 AI050409

National Institutes of Health

Grant: 5R01MH116695-05

Towards Suppression and Elimination of HIV in the CNS

National Institutes of Health

Grant: 5P30AI050409-20

Center for AIDS Research at Emory University

FWCI

0.02

Citation Percentile

0.4%

Citation Trend

2023

2025

hybridLicense: public-domain

journalhttps://academic.oup.com/cid/article-pdf/73/11/e3980/41608106/ciaa1210.pdf

publisherhttps://academic.oup.com/cid/article-pdf/73/11/e3980/41608106/ciaa1210.pdf

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1210/35042832/ciaa1210.pdf

journalhttps://doi.org/10.1093/cid/ciaa1210

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32797226

Fields of Study

COVID-19 Clinical Research StudiesPancreatitis Pathology and TreatmentDermatological and COVID-19 studies0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

SARS-CoV-2COVID-19 Drug TreatmentAzetidinesHumansPurinesPyrazolesSulfonamides

Keywords

MedicineCoagulopathyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirusConsumptive CoagulopathyBetacoronavirusDiseaseInfectious disease (medical specialty)Internal medicineOutbreakMicrobiology (medical)SulfonamidesInfectious DiseasesPurinesSARS-CoV-2AzetidinesHumansPyrazolesOnline Only ArticlesCOVID-19 Drug Treatment

Sustainable Development Goals

SDG 0: Good health and well-being

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al

FAIR Checklist

Authors (4)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)